Pure Global
NCT06415383

The Effects of Vitamin B6 Supplementation on Pain Thresholds and Tolerance

Testing the Effects of High-dose Vitamin B6 Supplements on Pain Thresholds and Tolerance in Healthy Adults
University of Reading·Phase 1·ClinicalTrials.gov·drugRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Pain
Drug/Device/Intervention
Vitamin B6 100 MG
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
University of Reading
Location
Reading, United Kingdom
Timeline & enrollment
Phase
Phase 1
Start date
May 01, 2024
End date
Dec 01, 2025
Enrollment
20 participants
Primary outcome

Thermal sensory threshold,Thermal pain threshold,Electrical pain sensitivity,Thermal pain tolerance,Cold immersion pain tolerance,Pain wind-up

Summary

This clinical trial aims to explore the effect of Vitamin B6 supplementation on pain
 thresholds and tolerance in healthy adults using thermal and electrical stimulation.
 Researchers will compare a placebo group to high-dose Vitamin-B6 to see if vitamin B6
 increases pain thresholds and tolerance.

ICD-10 classifications
Pain, unspecifiedPain, not elsewhere classifiedPain in limbAcute painOther chronic pain
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06415383
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06415383 through Pure Global AI's free database. This Phase 1 trial is sponsored by University of Reading and is currently Recruiting. The study focuses on Pain. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.